Navigation Links
Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
Date:2/13/2008

nt of revenue in 2008, consistent with R&D

spending in 2007. Genzyme's pipeline is concentrated on programs in

mid- to late-stage development and includes more than 25 phase 2

studies and several major pivotal studies. The company is re-

prioritizing its R&D programs to make space for mipomersen, a lipid-

lowering product currently in phase 3 clinical trials for high-risk

cardiovascular disease patients. Mipomersen, which Genzyme is in the

process of licensing from Isis Pharmaceuticals Inc., will strengthen an

already substantial pipeline. The product will join Mozobil and

alemtuzumab at the forefront of a development portfolio with

significant potential to drive Genzyme's growth beyond 2011.

Tax Rate

-- Genzyme's non-GAAP net tax rate this year is expected to be

approximately 31 percent. The GAAP tax rate is expected to be 30

percent.

Capital Expenditures

-- Capital expenditures are expected to total approximately $500 million

this year. Genzyme continues to make a significant investment in

manufacturing capacity to support the growth of existing products and

to prepare for the launch of products in late-stage development.

-- Genzyme is making steady progress toward beginning commercial

production of Myozyme at its Geel, Belgium, manufacturing plant.

Process validation runs for Myozyme production at the site are expected

to occur this year, with approval of commercial production anticipated

next year. Genzyme is beginning the construction of a new

manufacturing facility in Lyon for Thymoglobulin production.

Development Programs

Mozobil for stem-cell transplantation

-- Mozobil is an innovative product intended to facilitate and improve the

outcome of stem-cell transplantation procedures. In two pivotal

clinic
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine news :

1. Genzyme Receives FDA Response Letter on Synvisc-One(TM)
2. Bioenvision Shareholders Approve Acquisition by Genzyme Corporation
3. Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Delaware Court Approves Bioenvision, Genzyme Joint Petition
6. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
7. Liquent Insight Publisher 3.6 Delivers Advanced Submission Capabilities
8. March of Dimes Delivers a New Look
9. Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
10. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study
11. Gleevec, the targeted cancer pill, delivers more good news to patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2014)... Angeldress.co.uk, the distinguished wedding dress manufacturer ... dress fans. The company has recently updated its official ... the holiday season, Angeldress Blog has recommended ... , Angeldress.co.uk prides itself in offering a huge selection ... All the company’s outfits are very carefully selected based ...
(Date:12/20/2014)... York, NY (PRWEB) December 20, 2014 The ... has caused quite a stir, not only in Hollywood, but ... on December 18th , the ripples of that attack are ... executives’ very jobs at risk. But they are not ... correspondences exposed could be in for some embarrassing times ahead, ...
(Date:12/20/2014)... Xarelto bleeding lawsuits filed by men ... and other serious side effects will be consolidated in ... coordinated pretrial proceedings, Wright & Schulte LLC reports. The ... order Friday to transfer 21 Xarelto lawsuits and over ... to the Louisiana district court for coordination by Judge ...
(Date:12/20/2014)... Today, Balfleet.com, one of the most outstanding dressmakers in ... on its Mother of the Bride Dresses ... bride dresses from Balfleet.com feature gorgeous looks and delicate ... pride in providing high quality dresses to its clients ... on our mother of the bride dresses, and we ...
(Date:12/19/2014)... Sweetdressy.com , a leading wedding dress manufacturer ... of cheap prom dresses for ladies worldwide. The prom ... and clients can buy these dresses at the website ... cool cuts and delicate craftsmanship, and most of them ... Discount shipping costs are available for all of their ...
Breaking Medicine News(10 mins):Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 2Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 3Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 4Health News:Balfleet.com is Offering 50%-70% Off of its Mother of the Bride Dresses 2Health News:Cheap Prom Dresses Online Now at Sweetdressy.com 2
... in midlife underreport the number of hot flashes that they ... are linked to poor verbal memory, according to a study ... The study is published online and will appear in the ... is the first study to explore the relationship between objectively ...
... 16 The American,Association for Homecare (AAHomecare) applauded ... that will delay for at least 18 months ... home,medical equipment and services. The bill, H.R. 6252, ... of 2008.", The competitive acquisition or "competitive ...
... as surgery and pharmaceuticals were important to medicine in the ... the 21st century,and biofeedback is an important component of Behavioral ... Basmajian, Member ... One of the World,s Leading Sport,Psychologists that trained Canada,s top ...
... can lessen the cholesterol-lowering drugs, effectiveness , , MONDAY, June ... production of one protein helps explain why some people ... researchers report. , Statins include blockbuster medications such as ... as HMGCR, plays a critical role in production of ...
... where, but calls it ,most fruitful, lead in ongoing ... News) -- Although a U.S. government investigation into ... for the contamination, health officials said Monday they are ... nine cases in one location. , "The cluster ...
... Staff, and 7 other HFI usability, experts speak ... research topics including, ,Who are We ... YORK, June 16 Human Factors International (HFI),the ... "platinum",sponsorship of the 2008 Usability Professionals, Association International,Conference. ...
Cached Medicine News:Health News:Hot flashes underreported and linked to forgetfulness 2Health News:American Association for Homecare Applauds Bill to Delay the Flawed Medicare Bidding Program for Home Medical Equipment 2Health News:American Association for Homecare Applauds Bill to Delay the Flawed Medicare Bidding Program for Home Medical Equipment 3Health News:Biofeedback Workshops & Distance Learning Offer Credits and Training Options 2Health News:Research Shows Why Statins Don't Work for Everyone 2Health News:FDA Narrowing Tainted Tomato Probe to One Cluster 2Health News:FDA Narrowing Tainted Tomato Probe to One Cluster 3Health News:Human Factors International Sponsors Usability Professionals' Association (UPA) 2008 International Conference 2Health News:Human Factors International Sponsors Usability Professionals' Association (UPA) 2008 International Conference 3
(Date:12/17/2014)... , The new Dompé website aims ... the biopharmaceutical Group,s national and international clinical research activities ... launched institutional website that is receiving accolades from all over ... chapter in the fascinating story of Drug Discovery   , ... on the world of clinical research, ranging from information for ...
(Date:12/17/2014)... N.J. , Dec. 17, 2014  IGI Laboratories, ... today the closing of its offering of $125 million ... 2019 (the "Notes").  The Notes were offered and sold ... under the Securities Act of 1933, as amended (the ... a fixed rate of 3.75% per year, payable semiannually ...
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 17, ... (CTMC), and Integrated Clinical Trial Services, LLC (ICTS), ... for clinical trials announce that they have formed ... Services (i-CTMS). i-CTMS will provide a broad range ... biotechnology and medical device companies. i-CTMS ...
Breaking Medicine Technology:Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
... Oct. 10, 2011 Complementary and alternative medical (CAM) ... in the United States, especially among older patients and ... can have serious and potentially harmful side effects when ... to a review article in the Journal of ...
... 10, 2011 Groupe Athena, Inc. (Pink sheets GATA.PK) announced ... September 30, 2011 which generated pretax earnings of $1,566,906, or ... same period. With the most recent strong quarter, trailing twelve ... record quarterly revenue was significant in that it equaled nearly ...
Cached Medicine Technology:Herbal Supplements May Cause Dangerous Drug Interactions in Orthopaedic Surgery Patients 2Herbal Supplements May Cause Dangerous Drug Interactions in Orthopaedic Surgery Patients 3Herbal Supplements May Cause Dangerous Drug Interactions in Orthopaedic Surgery Patients 4Groupe Athena, Inc. Reports Record First Quarter Revenues 2Groupe Athena, Inc. Reports Record First Quarter Revenues 3
4.625 inches, curved blade 4 mm....
Alvis foreign body spud 4 3/4 inches, oval curette 1 x 3 mm with fine point....
DIX foreign body spud 4 3/4 inches, 1.7 x 15 mm blade....
In reversible handle for removing foreign bodies....
Medicine Products: